BRD2 directly regulates multiple TH17-associated cytokines, including IL17, IL21, and GMCSF32, and altered TH17 cells mediate autoimmune conditions, including multiple sclerosis, psoriasis, rheumatoid arthritis, and CD32. This evidence concerns the gene BRD2 and multiple sclerosis.